TY - JOUR
AU - X. Wang
AU - Z. Meisel
AU - K. Kellom
AU - J. Whitaker
AU - D. Strane
AU - A. Chatterjee
AU - R. Rosenquist
AU - M. Matone
A1 - 
AD - PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA.; Department of Emergency Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
AN - 38045493
BT - Drug Alcohol Depend Rep
C5 - Opioids & Substance Use; Healthcare Disparities
DA - Dec
DO - 10.1016/j.dadr.2023.100206
DP - NLM
ET - 20231110
JF - Drug Alcohol Depend Rep
LA - eng
PY - 2023
SN - 2772-7246
SP - 100206
ST - Receipt and duration of buprenorphine treatment during pregnancy and postpartum periods in a national privately-insured cohort
T1 - Receipt and duration of buprenorphine treatment during pregnancy and postpartum periods in a national privately-insured cohort
T2 - Drug Alcohol Depend Rep
TI - Receipt and duration of buprenorphine treatment during pregnancy and postpartum periods in a national privately-insured cohort
U1 - Opioids & Substance Use; Healthcare Disparities
U3 - 10.1016/j.dadr.2023.100206
VL - 9
VO - 2772-7246
Y1 - 2023
ER -